Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease

J Alzheimers Dis. 2014;39(1):191-210. doi: 10.3233/JAD-131490.

Abstract

Background: Immune system activation is frequently reported in patients with Alzheimer's disease (AD). However, it remains unknown whether this is a cause, a consequence, or an epiphenomenon of brain degeneration.

Objective: The present study examines whether immunological abnormalities occur in a well-established murine AD model and if so, how they relate temporally to behavioral deficits and neuropathology.

Methods: A broad battery of tests was employed to assess behavioral performance and autoimmune/inflammatory markers in 3xTg-AD (AD) mice and wild type controls from 1.5 to 12 months of age.

Results: Aged AD mice displayed severe manifestations of systemic autoimmune/inflammatory dise6ase, as evidenced by splenomegaly, hepatomegaly, elevated serum levels of anti-nuclear/anti-dsDNA antibodies, low hematocrit, and increased number of double-negative T splenocytes. However, anxiety-related behavior and altered spleen function were evident as early as 2 months of age, thus preceding typical AD-like brain pathology. Moreover, AD mice showed altered olfaction and impaired "cognitive" flexibility in the first 6 months of life, suggesting mild cognitive impairment-like manifestations before general learning/memory impairments emerged at an older age. Interestingly, all of these features were present in 3xTg-AD mice prior to significant amyloid-β or tau pathology.

Conclusion: The results indicate that behavioral deficits in AD mice develop in parallel with systemic autoimmune/inflammatory disease. These changes antedate AD-like neuropathology, thus supporting a causal link between autoimmunity and aberrant behavior. Consequently, 3xTg-AD mice may be a useful model in elucidating the role of immune system in the etiology of AD.

Keywords: 3xTg-AD model; Alzheimer's disease; amyloidosis; anxiety; autoimmunity; hepatomegaly; inflammation; mild cognitive impairment; olfaction; splenomegaly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / complications
  • Alzheimer Disease / immunology*
  • Alzheimer Disease / pathology
  • Alzheimer Disease / physiopathology
  • Animals
  • Antibodies, Antinuclear / metabolism*
  • Autoantibodies / blood*
  • Biomarkers / metabolism
  • Brain / pathology
  • Disease Models, Animal
  • Hematocrit
  • Kidney / pathology
  • Liver / pathology
  • Lymphocyte Count
  • Male
  • Maze Learning
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Organ Size
  • Spleen / immunology*
  • Spleen / pathology
  • Splenomegaly / complications
  • T-Lymphocytes / pathology

Substances

  • Antibodies, Antinuclear
  • Autoantibodies
  • Biomarkers